Interactions of Black Cohosh with Cancer Therapy
黑升麻与癌症治疗的相互作用
基本信息
- 批准号:6931085
- 负责人:
- 金额:$ 22.07万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-08-01 至 2007-07-31
- 项目状态:已结题
- 来源:
- 关键词:MCF7 cellalternative medicineangiospermsautologous transplantationbone marrowbreast neoplasmscisplatincyclophosphamidecytotoxicitydoxorubicindrug interactionshematopoietic stem cellslaboratory mouseliquid chromatography mass spectrometrymedicinal plantsneoplasm /cancer chemotherapyneoplasm /cancer radiation therapypaclitaxelplant extracts
项目摘要
DESCRIPTION (provided by applicant)
Black cohosh (Cimicifuga racemosa), is a widely used herbal medicine which is often assumed to be a safe and effective natural remedy for menopausal symptoms in women who have been advised by their doctors to avoid hormone replacement therapy (HRT) because they are at high risk for breast cancer or to discontinue HRT because they have been diagnosed with breast cancer. Some vendors of this herb advise that black cohosh "may help" breast cancer. This herb is widely used by breast cancer patients while they are receiving chemotherapy and radiation therapy. Studies in our laboratory showed that three commercially available black cohosh extracts significantly increase the response of breast cancer cells in cell culture to Adriamycin. Further tests with one of these extracts showed moderate sensitization to Taxotere, slight protection from Cisplatin, and no discernable effect on radiosensitivity. The goal of this project is to examine the therapeutic implications of these findings. A well characterized transplantable syngeneic tumor host system, the EMT6 mouse mammary carcinoma growing in SPF BALB/c Rw mice, will be used to study the effect of black cohosh on the response of tumors and normal tissues in vivo to cancer therapy. Effects on tumors will be assessed using quantitative experiments in which the growth of control tumors, tumors treated with drug alone, and tumors treated with black cohosh plus drug is measured and compared. We will also examine the effects of these treatments on the survival of the progenitor cells (CFU-GM/MK) of the bone marrow, a tissue which limits the intensity of cancer chemotherapy. Another series of studies will examine the effect of black cohosh extracts on the toxicity of Adriamycin, Taxotere, Cisplatin and radiation to human breast cancer cells in cell culture. These studies will assess whether the effects seen in mouse cells also occur in human cells. Data from our past studies suggest that this herb could change the effectiveness of standard cancer chemotherapeutic agents in treating cancer and could alter the toxicities of these drugs. This project will assess these possibilities. The findings will show whether this herb is inactive and harmless, potentially dangerous to breast cancer patients, or of potential value in the treatment of this disease.
描述(由申请人提供)
黑升麻(Cimicifuga racemosa)是一种广泛使用的草药,通常被认为是治疗更年期症状的安全有效的天然药物,对于医生建议避免激素替代疗法(HRT)的女性,因为她们是乳腺癌的高风险人群,或者因为被诊断出患有乳腺癌而停止激素替代疗法。这种草药的一些供应商建议黑升麻“可能有助于”乳腺癌。这种草药被乳腺癌患者广泛使用,而他们正在接受化疗和放射治疗。我们实验室的研究表明,三种市售的黑升麻提取物显着增加细胞培养物中的乳腺癌细胞对阿霉素的反应。 对其中一种浸提液的进一步试验显示,对泰索帝中度致敏,对顺铂轻微保护,对放射敏感性无明显影响。这个项目的目标是研究这些发现的治疗意义。一个充分表征的可移植的同源肿瘤宿主系统,EMT 6小鼠乳腺癌生长在SPF BALB/c Rw小鼠,将被用来研究黑升麻对肿瘤和正常组织在体内对癌症治疗的反应的影响。将使用定量实验评估对肿瘤的作用,其中测量并比较对照肿瘤、单独用药物治疗的肿瘤和用黑升麻加药物治疗的肿瘤的生长。我们还将研究这些治疗对骨髓祖细胞(CFU-GM/MK)存活的影响,骨髓是一种限制癌症化疗强度的组织。另一系列研究将检查黑升麻提取物对阿霉素、泰索帝、顺铂和辐射对细胞培养中的人类乳腺癌细胞的毒性的影响。这些研究将评估在小鼠细胞中观察到的效应是否也发生在人类细胞中。我们过去的研究数据表明,这种草药可以改变标准癌症化疗药物治疗癌症的有效性,并可以改变这些药物的毒性。本项目将评估这些可能性。研究结果将显示这种草药是否无活性和无害,对乳腺癌患者有潜在危险,或者在治疗这种疾病方面有潜在价值。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SARA ROCKWELL其他文献
SARA ROCKWELL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SARA ROCKWELL', 18)}}的其他基金
Interactions of Black Cohosh with Cancer Therapy
黑升麻与癌症治疗的相互作用
- 批准号:
6818052 - 财政年份:2004
- 资助金额:
$ 22.07万 - 项目类别:
PERFLUOROCHEMICAL EMULSIONS AS ADJUNCTS TO RADIOTHERAPY
全氟化学乳剂作为放射治疗的辅助剂
- 批准号:
3172837 - 财政年份:1984
- 资助金额:
$ 22.07万 - 项目类别:
PERFLUOROCHEMICAL EMULSIONS AS ADJUNCTS TO RADIOTHERAPY
全氟化学乳剂作为放射治疗的辅助剂
- 批准号:
3172839 - 财政年份:1984
- 资助金额:
$ 22.07万 - 项目类别:
PERFLUOROCHEMICAL EMULSIONS AS ADJUNCTS TO RADIO-
全氟化学乳液作为放射性添加剂
- 批准号:
3172832 - 财政年份:1984
- 资助金额:
$ 22.07万 - 项目类别:
PERFLUOROCHEMICAL EMULSIONS AS ADJUNCTS TO RADIOTHERAPY
全氟化学乳剂作为放射治疗的辅助剂
- 批准号:
3172838 - 财政年份:1984
- 资助金额:
$ 22.07万 - 项目类别:
PERFLUOROCHEMICAL EMULSIONS AS ADJUNCTS TO RADIOTHERAPY
全氟化学乳剂作为放射治疗的辅助剂
- 批准号:
3172833 - 财政年份:1984
- 资助金额:
$ 22.07万 - 项目类别:
PERFLUOROCHEMICAL EMULSIONS AS ADJUNCTS TO RADIOTHERAPY
全氟化学乳剂作为放射治疗的辅助剂
- 批准号:
3172834 - 财政年份:1984
- 资助金额:
$ 22.07万 - 项目类别:
PERFLUOROCHEMICAL EMULSIONS AS ADJUNCTS TO RADIOTHERAPY
全氟化学乳剂作为放射治疗的辅助剂
- 批准号:
3172835 - 财政年份:1984
- 资助金额:
$ 22.07万 - 项目类别:
相似海外基金
Complementary and alternative medicine for drug-induced gingival overgrowth: inhibitory effect of TRPA1 channel by lutein
药物性牙龈增生的补充和替代医学:叶黄素对 TRPA1 通道的抑制作用
- 批准号:
23K09321 - 财政年份:2023
- 资助金额:
$ 22.07万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Complementary alternative medicine contributes to attenuate orofacial pain: anesthetic and anti-inflammatory effects of phytochemical
补充替代医学有助于减轻口面部疼痛:植物化学物质的麻醉和抗炎作用
- 批准号:
22K10232 - 财政年份:2022
- 资助金额:
$ 22.07万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Negotiating distinctions between conventional and alternative medicine in the English- and French-language Wikipedias
英语和法语维基百科中讨论传统医学和替代医学之间的区别
- 批准号:
AH/V013203/1 - 财政年份:2021
- 资助金额:
$ 22.07万 - 项目类别:
Research Grant
Systematic study on legal regulations for complementary and alternative medicine
补充替代医学法律法规的系统研究
- 批准号:
19K21680 - 财政年份:2019
- 资助金额:
$ 22.07万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Contribution of complementary alternative medicine to the orthodontic tooth-movement induced inflammatory pain: a possible role of dietary constituent
补充替代医学对正畸牙齿移动引起的炎症性疼痛的贡献:饮食成分的可能作用
- 批准号:
19K10415 - 财政年份:2019
- 资助金额:
$ 22.07万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Application of complementary and alternative medicine for breast cancer based on kinetic characteristics of food components
基于食物成分动力学特征的乳腺癌补充替代医学应用
- 批准号:
18K14416 - 财政年份:2018
- 资助金额:
$ 22.07万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the Mechanism of Care Effectiveness Using Complementary and Alternative Medicine Material Detergent for Radiation Skin Damage
阐明补充和替代药物材料清洁剂对放射性皮肤损伤的护理效果机制
- 批准号:
18K17460 - 财政年份:2018
- 资助金额:
$ 22.07万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Quality of clinical research papers on complementary and alternative medicine: evaluation with modified systematic reviews
补充和替代医学临床研究论文的质量:用修改后的系统评价进行评估
- 批准号:
17K08938 - 财政年份:2017
- 资助金额:
$ 22.07万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Formulation for the Application of the Energy Therapy "Reiki" as Complementary and Alternative Medicine for Cancer Patient
应用能量疗法“灵气”作为癌症患者的补充和替代医学的配方
- 批准号:
16K15906 - 财政年份:2016
- 资助金额:
$ 22.07万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Boundaries between Orthodox Medicine and Alternative Medicine
正统医学与替代医学之间的界限
- 批准号:
16K21422 - 财政年份:2016
- 资助金额:
$ 22.07万 - 项目类别:
Grant-in-Aid for Young Scientists (B)